Concurrent inhibition of IDH and methyltransferase maximizes therapeutic efficacy in IDH mutant acute myeloid leukemia

Detalles Bibliográficos
Autores principales: Zeng, Zhihong, Konopleva, Marina
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Fondazione Ferrata Storti 2021
Materias:
Editorials
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7849332/
https://www.ncbi.nlm.nih.gov/pubmed/33522781
http://dx.doi.org/10.3324/haematol.2020.266809
_version_ 1783645283295428608
author Zeng, Zhihong
Konopleva, Marina
author_facet Zeng, Zhihong
Konopleva, Marina
author_sort Zeng, Zhihong
collection PubMed
description
format Online
Article
Text
id pubmed-7849332
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Fondazione Ferrata Storti
record_format MEDLINE/PubMed
spelling pubmed-78493322021-02-03 Concurrent inhibition of IDH and methyltransferase maximizes therapeutic efficacy in IDH mutant acute myeloid leukemia Zeng, Zhihong Konopleva, Marina Haematologica Editorials Fondazione Ferrata Storti 2021-02-01 /pmc/articles/PMC7849332/ /pubmed/33522781 http://dx.doi.org/10.3324/haematol.2020.266809 Text en Copyright© 2021 Ferrata Storti Foundation http://creativecommons.org/licenses/by-nc/4.0/ This article is distributed under the terms of the Creative Commons Attribution Noncommercial License (by-nc 4.0) which permits any noncommercial use, distribution, and reproduction in any medium, provided the original author(s) and source are credited.
spellingShingle Editorials
Zeng, Zhihong
Konopleva, Marina
Concurrent inhibition of IDH and methyltransferase maximizes therapeutic efficacy in IDH mutant acute myeloid leukemia
title Concurrent inhibition of IDH and methyltransferase maximizes therapeutic efficacy in IDH mutant acute myeloid leukemia
title_full Concurrent inhibition of IDH and methyltransferase maximizes therapeutic efficacy in IDH mutant acute myeloid leukemia
title_fullStr Concurrent inhibition of IDH and methyltransferase maximizes therapeutic efficacy in IDH mutant acute myeloid leukemia
title_full_unstemmed Concurrent inhibition of IDH and methyltransferase maximizes therapeutic efficacy in IDH mutant acute myeloid leukemia
title_short Concurrent inhibition of IDH and methyltransferase maximizes therapeutic efficacy in IDH mutant acute myeloid leukemia
title_sort concurrent inhibition of idh and methyltransferase maximizes therapeutic efficacy in idh mutant acute myeloid leukemia
topic Editorials
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7849332/
https://www.ncbi.nlm.nih.gov/pubmed/33522781
http://dx.doi.org/10.3324/haematol.2020.266809
work_keys_str_mv AT zengzhihong concurrentinhibitionofidhandmethyltransferasemaximizestherapeuticefficacyinidhmutantacutemyeloidleukemia
AT konoplevamarina concurrentinhibitionofidhandmethyltransferasemaximizestherapeuticefficacyinidhmutantacutemyeloidleukemia

Ejemplares similares